SCHEMBL548161

SCHEMBL548161

O=Cc1ccccc1C1CCC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.50
KMT2A Q03164 2/20 0.50
MEN1 O00255 1/20 0.50
THRB P10828 1/20 0.50
BLM P54132 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
ALDH1A1 P00352 2/20 0.41
TSHR P16473 1/20 0.41
TRIM24 O15164 1/20 0.41
TRIM33 Q9UPN9 1/20 0.41
PTGDR2 Q9Y5Y4 1/20 0.38
HPGD P15428 1/20 0.38
HTT P42858 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
PTGS2 P35354 1/20 0.37
GAA P10253 1/20 0.35
SRC P12931 2/20 0.35
ERN1 O75460 1/20 0.34
HTR2C P28335 2/20 0.34
CA1 P00915 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL547607 0.98 LMNA (0.48) LMNAKMT2AMEN1THRBBLM
SCHEMBL31415807 0.98 LMNA (0.48) LMNAKMT2AMEN1THRBBLM
SCHEMBL197356 0.96 MEN1 (0.46) LMNAKMT2AMEN1THRBBLM
SCHEMBL21647623 0.96 MEN1 (0.46) LMNAKMT2AMEN1THRBBLM
SCHEMBL22284134 0.96 MEN1 (0.46) LMNAKMT2AMEN1THRBBLM
SCHEMBL11675315 0.96 MEN1 (0.46) LMNAKMT2AMEN1THRBBLM
SCHEMBL14237042 0.96 MEN1 (0.46) LMNAKMT2AMEN1THRBBLM
SCHEMBL14236917 0.96 MEN1 (0.46) LMNAKMT2AMEN1THRBBLM
SCHEMBL548147 0.93 LMNA (0.52) LMNAKMT2AMEN1THRBBLM
SCHEMBL6764461 0.84 MEN1 (0.43) LMNAKMT2AMEN1THRBBLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112513737-B Underlayer film forming composition 三菱瓦斯化学株式会社 2024-11-15 CN disclosed
CN-116621897-B Scopolamine derivatives, preparation method and medical application thereof 中国药科大学 2024-07-09 CN disclosed
CN-112218844-B Compound, resin, composition, resist pattern forming method, circuit pattern forming method, and resin purifying method 三菱瓦斯化学株式会社 2024-04-26 CN disclosed
CN-111655662-B Compound, resin, composition, resist pattern forming method, circuit pattern forming method, and resin purifying method 三菱瓦斯化学株式会社 2023-09-26 CN disclosed
US-11747728-B2 Compound, resin, composition, resist pattern formation method, circuit pattern formation method and method for purifying resin MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2023-09-05 US disclosed
CN-116621897-A Scopolamine derivatives, preparation method and medical application thereof 中国药科大学 2023-08-22 CN disclosed
CN-116282078-A Salt recovery solution and method of using the same 阿克福特斯技术有限公司 2023-06-23 CN disclosed
CN-111225875-B Salt recovery solution and method of using salt recovery solution 阿克福特斯技术有限公司 2023-04-11 CN disclosed
US-20220144738-A1 COMPOUND, RESIN, COMPOSITION, RESIST PATTERN FORMATION METHOD, CIRCUIT PATTERN FORMATION METHOD, AND METHOD FOR PURIFYING RESIN MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2022-05-12 US disclosed
CN-113891760-A Solvent drying compositions and related methods 阿克福特斯技术有限公司 2022-01-04 CN disclosed
US-20120156615-A1 CYCLIC COMPOUND, PROCESS FOR PRODUCTION OF THE CYCLIC COMPOUND, RADIATION-SENSITIVE COMPOSITION, AND METHOD FOR FORMATION OF RESIST PATTERN MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2012-06-21 US disclosed
US-8110334-B2 Radiation-sensitive composition MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2012-02-07 US disclosed
US-20100047709-A1 RADIATION-SENSITIVE COMPOSITION MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2010-02-25 US disclosed
WO-2009133831-A1 PHENYLPROPIONIC ACID DERIVATIVE AND USE THEREOF 旭化成ファーマ株式会社 (JP) 2009-11-05 WO disclosed
EP-2080750-A1 RADIATION-SENSITIVE COMPOSITION Mitsubishi Gas Chemical Company, Inc. (JP) 2009-07-22 EP disclosed
US-6146811-A Photoresist using dioxaspiro ring-substituted acryl derivatives KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2000-11-14 US disclosed
EP-0414180-A2 Hydroxylated ene ketones, acetylenic grignards and hydroxylated yne ketones therefrom MARION MERRELL DOW INC. (US) 1991-02-27 EP disclosed
EP-0414180-A2 Hydroxylated ene ketones, acetylenic grignards and hydroxylated yne ketones therefrom MARION MERRELL DOW INC. (US) 1991-02-27 EP disclosed
US-4973756-A Hydroxylated ene ketones, acetylenic grignards and hydroxylated yne ketones therefrom MARION LABORATORIES, INC. (US) 1990-11-27 US disclosed
US-4973756-A Hydroxylated ene ketones, acetylenic grignards and hydroxylated yne ketones therefrom MARION LABORATORIES, INC. (US) 1990-11-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11747728-B2 Compound, resin, composition, resist pattern formation method, circuit pattern formation method and method for purifying resin RER1, FEM1B, UNC119 LMNA 2105/4885KMT2A 1359/4885MEN1 1546/4885
US-20100047709-A1 RADIATION-SENSITIVE COMPOSITION C1S, C9, RAD51 LMNA 286/4885KMT2A 645/4885MEN1 1910/4885
US-20120156615-A1 CYCLIC COMPOUND, PROCESS FOR PRODUCTION OF THE CYCLIC COMPOUND, RADIATION-SENSITIVE COMPOSITION, AND METHOD FOR FORMATION OF RESIST PATTERN RAD1, CCNE1, CCNA1 LMNA 559/4885KMT2A 3802/4885MEN1 400/4885
US-20220144738-A1 COMPOUND, RESIN, COMPOSITION, RESIST PATTERN FORMATION METHOD, CIRCUIT PATTERN FORMATION METHOD, AND METHOD FOR PURIFYING RESIN RER1, UNC119, FEM1B LMNA 2688/4885KMT2A 1129/4885MEN1 1697/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.